Your browser doesn't support javascript.
Antiglutamate acid decarboxylase seropositive brain stem encephalitis.
AlAbdulghafoor, Faye; Behbehani, Raed; Johar, Abbas; Alroughani, Raed.
  • AlAbdulghafoor F; Neurology, King's College London, London, UK f_abdulghafour@icloud.com.
  • Behbehani R; Ophthalmology, Ibn-Sina Hospital, Kuwait, Kuwait.
  • Johar A; Ministry of Health Kuwait, Kuwait City, Kuwait.
  • Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
BMJ Case Rep ; 16(3)2023 Mar 10.
Article in English | MEDLINE | ID: covidwho-2248741
ABSTRACT
This is a case of a previously healthy female in her fourties presenting with a subacute presentation of bilateral horizontal gaze restriction, with bilateral lower motor facial palsy. The patient's daughter has type 1 diabetes. On investigation, the patient's MRI revealed a lesion in the dorsal medial pons. Cerebrospinal fluid analysis revealed albuminocytological dissociation, with a negative autoimmune panel. The patient was treated with intravenous immunoglobulin, and methylprednisolone for a total of 5 days and showed mild improvement. The patient had raised serum antiglutamic acid decarboxylase (anti-GAD) levels, and the final diagnosis of GAD seropositive brain stem encephalitis was made.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Carboxy-Lyases / Encephalitis Type of study: Case report / Diagnostic study Limits: Female / Humans Language: English Year: 2023 Document Type: Article Affiliation country: Bcr-2022-254026

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Carboxy-Lyases / Encephalitis Type of study: Case report / Diagnostic study Limits: Female / Humans Language: English Year: 2023 Document Type: Article Affiliation country: Bcr-2022-254026